CHICAGO, June 11, 2013 /PRNewswire/ -- JBT Corporation (NYSE: JBT) today announced it received an $8 million order from Ohio State University Wexner Medical Center for the supply and integration of automatic guided vehicle (AGV) products and services.
This order includes both upgrading the existing fleet of AGVs at the medical center and delivering additional AGVs to support operations at the new James Cancer Hospital and Solove Research Institute and Critical Care Center.
"This medical center has been a valued JBT customer for over a decade and we are happy to continue this strong relationship with such a respected leader in the health care industry," stated John Lee, Vice President of JBT AeroTech.
All automated systems will be commissioned by the end of 2014.
About JBT Corporation JBT Corporation (NYSE: JBT) is a leading global solutions provider to the food processing and air transportation industries. JBT Corporation designs, manufactures, tests and services technologically sophisticated systems and products for regional and multi-national industrial food processing customers through its JBT FoodTech segment and for domestic and international air transportation customers through its JBT AeroTech segment. JBT Corporation employs approximately 3,200 people worldwide and operates sales, service, manufacturing and sourcing operations located in over 25 countries. For more information please visit www.jbtcorporation.com or http://www.jbtc-agv.com.
This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company's ability to control. These risks and uncertainties are described under the caption "Risk Factors" in the Company's Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission that may be accessed on the Company's website. The Company cautions shareholders and prospective investors that actual results may differ materially from those indicated by the forward-looking statements.
SOURCE JBT Corporation